Biomarker: F320-IgE Crayfish Freshwater
Overview
F320-IgE Crayfish Freshwater refers to allergen-specific IgE testing for freshwater crayfish, a crustacean shellfish exposure. Crayfish proteins can trigger IgE-mediated reactions, including urticaria, gastrointestinal symptoms, respiratory symptoms, and anaphylaxis, after ingestion or, less commonly, inhalational or occupational exposure. Sensitization may also occur through handling or processing of crustaceans. Evaluation of serum-specific IgE can help investigate suspected crayfish allergy when interpreted with the exposure history, symptoms, and other allergy testing, but a positive result indicates sensitization and does not by itself establish clinical allergy.
Clinical Use Cases
Evaluation of suspected IgE-mediated crayfish allergy: Measures serum IgE directed against crayfish proteins in patients with compatible symptoms after exposure.
Investigation of exposure-associated symptoms: Helps assess reactions occurring after eating crayfish or after occupational handling, cooking, or processing of crustaceans.
Serum-specific IgE assessment: Provides an in-vitro assessment when skin testing is unsuitable, unavailable, or considered potentially hazardous after a severe reaction.
Assessment alongside clinical history: Results should be interpreted with the type and amount of crayfish consumed, timing of symptoms, preparation method, previous tolerance, and co-factors such as exercise.
Evaluation of related crustacean sensitization: Testing may be considered with shrimp, crab, lobster, or other relevant crustaceans because shared allergens can produce positive IgE results across species.
Resolution of uncertain diagnoses: When history and blood or skin testing do not agree, an allergist may consider a medically supervised oral food challenge. This is the clinical reference procedure for determining whether exposure causes an actual allergic reaction and should not be performed at home.
Measurement Methods
Allergen-specific IgE testing: Immunoassays measure IgE antibodies in serum that bind proteins in a crayfish allergen extract. The result supports assessment of sensitization but does not independently predict reaction severity or confirm clinical allergy.
Extract-based testing: Uses a preparation containing proteins from the relevant crayfish species. Extract composition may vary and may not represent every clinically relevant crayfish allergen.
Component-resolved diagnostics: Measures IgE to individual allergenic proteins rather than only to a whole-food extract. Crayfish and other crustaceans contain several recognized allergen families, including tropomyosin, arginine kinase, myosin light chain, sarcoplasmic calcium-binding protein, and triosephosphate isomerase. Component testing may help characterize sensitization patterns, although species-specific component testing for crayfish is less established than extract-based testing and shrimp component testing.
Skin-prick testing: May provide complementary evidence of immediate-type sensitization, but it is an in-vivo procedure and can be affected by extract quality, medications, and skin conditions. Blood-based testing is often preferred when there is concern about reactions during in-vivo testing.
Oral food challenge: A controlled clinical procedure, rather than a laboratory measurement, that may be used when the diagnosis remains uncertain. It must be conducted by an appropriately trained clinician in a setting equipped to treat anaphylaxis.
Test Preparation and Influencing Factors
Fasting: Fasting is generally not required for serum-specific IgE blood testing.
Medications: Antihistamines commonly interfere with skin-prick testing but generally do not prevent measurement of serum-specific IgE. Medication review remains important when additional in-vivo testing is planned.
Timing of collection: Testing is interpreted in relation to the suspected reaction and exposure history. A negative result does not always exclude allergy when the history is strongly suggestive.
Total IgE concentration: Total IgE may help provide context for quantitative specific-IgE results, but a high total IgE concentration does not identify the responsible allergen and does not establish clinical allergy.
Age: IgE concentrations and the probability of clinical reactivity vary with age. Results should be interpreted using age-appropriate clinical context rather than a single universal threshold.
Cross-reactive sensitization: IgE binding to shared proteins, especially tropomyosin, may produce positive results to crayfish in patients primarily sensitized to other crustaceans, dust mites, cockroaches, or other arthropods.
Extract composition: Whole-crayfish extracts may contain variable amounts of individual allergens. A negative extract result may not exclude sensitization to an allergen that is poorly represented or unstable in the test preparation.
Clinical history: The timing, reproducibility, and nature of symptoms are central to interpretation. Sensitization without symptoms after eating crayfish is not equivalent to clinically confirmed allergy.
Reaction severity: The concentration of specific IgE does not reliably predict how severe a future reaction will be. A history of anaphylaxis requires specialist assessment regardless of the numerical test result.
Preparation and co-factors: Cooking, food processing, exercise, alcohol, infection, and medications may influence clinical reactions. These factors primarily affect clinical interpretation rather than the analytical measurement of serum IgE.
Cross-Reactivity
Other crustaceans: Tropomyosin is highly conserved among crayfish, shrimp, crab, and lobster. IgE binding to tropomyosin can therefore produce serologic cross-reactivity among crustacean species, although a positive result to one species does not prove that every related species causes symptoms.
Mollusks: Tropomyosin may also contribute to immunologic cross-reactivity between crustaceans and mollusks. The degree of clinically relevant cross-allergy varies between individuals.
Dust mites and cockroaches: Tropomyosin and other invertebrate proteins, including arginine kinase, can contribute to cross-reactive IgE binding between crustaceans, house dust mites, and cockroaches. This is particularly important when a patient has respiratory allergy or substantial environmental sensitization.
Protein families: Crayfish and other crustaceans contain tropomyosin, arginine kinase, myosin light chain, sarcoplasmic calcium-binding protein, troponin proteins, and triosephosphate isomerase. Some of these proteins are shared across arthropods and may contribute to positive component or extract-based tests.
Freshwater versus marine crustaceans: Human clinical studies indicate that some patients may react preferentially to freshwater or marine shrimp species, so broad cross-reactivity should not be assumed to be complete.
Clinical relevance: Immunologic cross-reactivity and clinical cross-allergy are not equivalent. Symptoms after exposure, supported by appropriately interpreted testing and, when necessary, a supervised food challenge, are needed to establish clinically meaningful allergy.
Synonyms
Common name: Freshwater crayfish
Common alternatives: Crayfish, crawfish, crawdad
Scientific and taxonomic group: Freshwater crayfish, family Astacidae or Cambaridae, depending on species
Representative species:Procambarus clarkii, commonly called red swamp crayfish
Allergen designation: Crayfish-specific IgE, freshwater crayfish IgE, F320 crayfish IgE
This information is provided for general educational purposes and is not medical advice. Biomarker information may describe testing methods, measurements, or interpretations that vary by laboratory or specific test. For details about a particular lab test, including biomarkers measured, specimen type, collection requirements, preparation, and turnaround time, please refer to the individual test description. Talk with a licensed health care provider about your results.
